CAR T-cell therapy demand is rising, prompting institutions to expand access and reduce care barriers, exemplified by Vanderbilt-Ingram Cancer Center's outpatient center. Dr. Oluwole emphasizes ...

Incannex Healthcare, the Melbourne-based clinical-stage biopharmaceutical company developing therapies for the treatment of obstructive sleep apnea, rheumatoid arthritis and generalized anxiety ...

Payers and providers are eager to elevate the patient journey, but for many patients, it still begins with friction. Extended wait times, complex intake processes, and unclear billing can derail the ...

Insurance claim denials have risen 16% from 2018 to 2024, affecting access to essential medications like insulin and albuterol. Denials often result from formulary exclusions, step therapy, and ...

In healthcare, where the cost of care is rising, organizations can’t afford to drive patients away due to inefficient systems ...

Patient engagement has matured from aspiration to necessity as precision medicine moves from laboratory concept to bedside. Cutting-edge therapies increasingly target narrowly defined genetic or ...

As healthcare organizations navigate large-scale EHR transitions in 2025, patient access is gaining renewed attention, not just as an operational dependency, but as a strategic capability. Rather than ...

Access to clinical notes enhances patient engagement and trust, and the 21st Century Cures Act enabled immediate electronic patient access in April 2021. Yet, technological advances may perpetuate ...

As healthcare organizations work to improve the patient experience, increase efficiency and achieve financial sustainability, many are introducing technology to simplify patient-provider interactions ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...